Q1 2021 Matinas BioPharma Holdings Inc Earnings Call Transcript
Hello, and welcome to the Matinas Biopharma's Q1 2021 Results Conference Call and Webcast. (Operator Instructions). As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Peter Vozzo, Investor Relations. Please go ahead.
Thank you, Kevin. Good morning, everyone, and thank you for joining the Matinas Biopharma First Quarter 2021 Results Conference Call. Early this morning, we issued a press release with our financial results along with business updates. This release is available on the Matinas Biopharma website under the Investors section.
Speaking on today's call will be Jerry Jabbour, Chief Executive Officer; and Keith Kucinski, Chief Financial Officer. We also have Dr. Terry Ferguson, Chief Medical Officer; and Dr. Terri Matkovits, Chief Development Officer, who will be available to answer questions during our Q&A session.
At this time, I would like to remind our listeners that remarks made during this call may state management's intentions,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |